| MolName | 3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-7-[[2-[[2-(4-formylpiperazin-1-yl)-5-oxo-8H-pyrido[2,3-d]pyrimidine-6-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| MolecularFormula | C32H30N12O10S2 |
| Smiles | OC(Cn1nnnc1SCC(CSC1C2NC(C(c(cc3)ccc3O)NC(C3=CNc(nc(N(CC4)CCN4C=O)nc4)c4C3=O)=O)=O)=C(C(O)=O)N1C2=O)=O |
| InChI | InChI=1S/C32H30N12O10S2/c45-14-41-5-7-42(8-6-41)31-34-9-18-24(49)19(10-33-25(18)37-31)26(50)35-21(15-1-3-17(46)4-2-15)27(51)36-22-28(52)44-23(30(53)54)16(12-55-29(22)44)13-56-32-38-39-40-43(32)11-20(47)48/h1-4,9-10,14,21-22,29,46H,5-8,11-13H2,(H,35,50)(H, |
| InChIK | GSWSZNOBAWTSID-UHFFFAOYSA-N |
| TotalMolweight | 806.796 |
| Molweight | 806.796 |
| MonoisotopicMass | 806.164928 |
| CLogP | -2.6244 |
| CLogS | -3.565 |
| H Acceptors | 22 |
| H Donors | 6 |
| TotalSurfaceArea | 548.58 |
| Relative PSA | 0.49639 |
| PolarSurfaceArea | 345.97 |
| Druglikeness | 8.6006 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | low |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.51786 |
| Fragments | 1 |
| Non HAtoms | 56 |
| NonCHAtoms | 24 |
| Electronegative Atoms | 24 |
| StereoCenters | 3 |
| Rotatable Bond | 12 |
| Rings Closures | 7 |
| Small Rings | 7 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 15 |
| Symmetricatoms | 4 |
| Amides | 4 |
| Aromatic Nitrogens | 6 |
| AcidicOxygens | 2 |
| StereoCon | unknown chirality |
Click to Load Molecule:
1 - 3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-7-[[2-[[2-(4-formylpiperazin-1-yl)-5-oxo-8H-pyrido[2,3-d]pyrimidine-6-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 2 - 3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-7-[[2-[[2-(4-formylpiperazin-1-yl)-5-oxo-8H-pyrido[2,3-d]pyrimidine-6-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid